During the past decade, Hospital Clínico Universitario Lozano Blesa conducted 175 clinical trials. In the 10-year time frame, 175 clinical trials started and 48 clinical trials were completed, i.e. on average, 27.4% percent of trials that started reached the finish line to date. In the past 5 years, 86 clinical trials started and 33 clinical trials were completed. i.e. 38.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clínico Universitario Lozano Blesa" #1 sponsor was "PETHEMA Foundation" with 34 trials, followed by "Spanish Breast Cancer Research Group" with 15 trials sponsored, "Boehringer Ingelheim" with 7 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 7 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored. Other sponsors include 209 different institutions and companies that sponsored additional 136 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clínico Universitario Lozano Blesa" #1 collaborator was "Merck Sharp & Dohme LLC" with 8 trials as a collaborator, "Instituto de Salud Carlos III" with 7 trials as a collaborator, "Hoffmann-La Roche" with 6 trials as a collaborator, "Pfizer" with 6 trials as a collaborator and "AstraZeneca" with 5 trials as a collaborator. Other collaborators include 197 different institutions and companies that were collaborators in the rest 170 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clínico Universitario Lozano Blesa" are "Breast Cancer" (16 trials), "Multiple Myeloma" (15 trials), "Coronary Artery Disease" (7 trials), "Acute Lymphoblastic Leukemia" (6 trials) and "Colorectal Cancer" (6 trials). Many other conditions were trialed in "Hospital Clínico Universitario Lozano Blesa" in a lesser frequency.

Most popular intervention types in "Hospital Clínico Universitario Lozano Blesa" are "Drug" (199 trials), "Other" (32 trials), "Procedure" (22 trials), "Biological" (16 trials) and "Device" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Cyclophosphamide" (13 trials), "Dexamethasone" (10 trials), "Prednisone" (10 trials) and "Carboplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clínico Universitario Lozano Blesa" are 237 trials for "All" genders, 40 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Clínico Universitario Lozano Blesa". 5 are not yet recruiting, 51 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 146 completed trials in Hospital Clínico Universitario Lozano Blesa, 1 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clínico Universitario Lozano Blesa, 12 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 97 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 32 trials, and there were also 16 trials that are defined as “Not Applicable".

Hospital Clínico Universitario Lozano Blesa has several departments that took part in Clinical trials: "Hospital Clinico Universitario Lozano Blesa; Servicio de Hematologia" - 3 trials